LASP1 and urinary bladder carcinoma: Moreover, overexpression of LASP-1 has been observed in a variety of malignant tumors such as metastatic breast cancer [11], ovarian cancer [13], bladder cancer [14], medulloblastoma [15], and hepatocellular carcinoma [16].